Human immunoglobulin (PH4) For intravenous injection (Guizhou Taibang Biological Products)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman immunoglobulin (PH4) For intravenous injection (Guizhou Taibang Biological Products)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsAgammaglobulinemiaPurpura, Thrombocytopenic, IdiopathicMucocutaneous Lymph Node Syndrome
Global Approved IndicationsAgammaglobulinemiaPurpura, Thrombocytopenic, IdiopathicMucocutaneous Lymph Node Syndrome
Approved Indications in ChinaAgammaglobulinemiaPurpura, Thrombocytopenic, IdiopathicMucocutaneous Lymph Node Syndrome
Original Approved Country/TerritoryMainland China
Original Approved Date2002/09/30
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGuizhou Taibang Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuizhou Taibang Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsAgammaglobulinemiaPurpura, Thrombocytopenic, IdiopathicMucocutaneous Lymph Node Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeJ06BA02
Related LinksN/A